Fundamentals of Liver Disease- Cirrhosis

4.65 (20 votes)

The Fundamentals of Liver Disease Cirrhosis unit currently does not offer CME, CE or MOC. This unit is available for viewing purposes only. A newly updated version will be available soon for credits or points. Check back for updates!

There is currently an anticipated shortage of trained providers capable of diagnosing and treating different liver diseases. As a result of this increased demand and limited specialists in the field, more and more front line providers are faced with these patients and do not have the experience or resources that will allow them to manage them appropriately.

The overall goal is to improve patient care by increasing learner competence and confidence in both proper patient identification and assessment and increasing learner performance in therapeutic options and on-treatment management strategies for patients. Patient outcomes will be improved as a result of the improvements in more providers understanding these key components in the management and care of patients with liver diseases.

Key topic areas:

Does My Patient Have Cirrhosis?

Natural History of Cirrhosis and General Management of the Compensated Patient

Varices and Variceal Hemorrhage

Ascites

Hyponatremia and Hepatorenal Syndrome

Hepatic Encephalopathy

Infections in cirrhosis

Pulmonary complications in the patient with cirrhosis

Does my patient with cirrhosis need to be referred for liver transplant?

 

COMPONENTS

Online presentations comprised of PowerPoint slides and accompanying audio and online pre- and post-tests and evaluations:

-9 online interactive, narrated modules 20 to 40 minutes in length

-Pre- and post-test questions for each module

Original release date: July 20, 2015
Expiration date: July 19, 2017
Review date: January 1 - November 30, 2017
Re-release date: December 1, 2017
Expiration date: November 30, 2019
Time to complete each module: 45-60 minutes

 

Copyright:

All faculty in this activity have given their permission for publication OR

©2017 AASLD

 

Contact Information

For questions on CE credit for this activity, email Certificate@AmedcoEmail.com

For questions on MOC/CME/CE content or the activity web site, contact education@aasld.org

Patrick S. Kamath

Guadalupe Garcia-Tsao

Dr. Garcia-Tsao is Professor of Medicine, Chief of Digestive Diseases and Program Director of the Hepatitis C Resource Center at Veteran’s Administration-Connecticut Healthcare System, as well as Director of Clinical and Translational Core at Yale Liver Center. She is a past president of AASLD. She received her M.D. and training at Universidad Nacional Autónoma de Mexico. Her primary research focus is on clinical research which focuses on cirrhosis and its complications, and she also is involved in the study of bacterial infections in cirrhosis, a complication that is often overlooked.

Juan G. Abraldes

Florence Wong

Thomas D. Boyer

Dr. Thomas D. Boyer is currently Professor of Medicine and Director of the Liver Research Institute at the University of Arizona School of Medicine in Tucson, Arizona. He has a longstanding interest in the complications of portal hypertension including bleeding varices, ascites, and hepatorenal syndrome. Dr. Boyer has published a number of papers in each of these areas of interest.

Jasmohan S. Bajaj

Puneeta Tandon

Dr. Tandon is an Associate Professor of Medicine, Director of the Cirrhosis Care Clinic and Transplant Hepatologist at the University of Alberta in Edmonton, Alberta, Canada. She completed her Gastroenterology and Hepatology training at the University of Alberta with fellowships at Yale University and the Hospital Clinic in Barcelona. Her clinical practice and research are focused on cirrhosis. Research interests include acute on chronic liver failure and its related complications, sarcopenia, frailty, nutrition, exercise therapy and the early integration of palliative care principles in cirrhosis.

Michael B. Fallon

Paul Martin

Key:

Complete
Failed
Available
Locked
Acknowledgement of View Only
Acknowledgement of View Only
Agree to terms to continue.
Agree to terms to continue.
Module 1: Does My Patient Have Cirrhosis?
Module 1: Does My Patient Have Cirrhosis?
Open to view video.
Open to view video.
Module 1 Evaluation
4 Questions
4 Questions Please complete the following evaluation form to share your feedback on this activity.
Module 2: Natural History of Cirrhosis and Management of Compensated Cirrhosis
Module 2- Natural History of Cirrhosis and Management of Compensated Cirrhosis (Enlgish)
Open to view video.
Open to view video.
Module 2 Evaluation
4 Questions
4 Questions Please complete the following evaluation form to share your feedback on this activity.
Module 3: Current Management of Portal Hypertension and Variceal Bleeding
Module 3: Current Management of Portal Hypertension and Variceal Bleeding (English)
Open to view video.
Open to view video.
Module 3: Current Management of Portal Hypertension and Variceal Bleeding (Spanish)
Open to view video.
Open to view video.
Module 3 Evaluation
4 Questions
4 Questions Please complete the following evaluation form to share your feedback on this activity.
Module 4: Ascites
Module 4: Ascites
Open to view video.
Open to view video.
Module 4 Evaluation
4 Questions
4 Questions Please complete the following evaluation form to share your feedback on this activity.
Module 5: Hyponatremia and Hepatorenal Syndrome
Module 5: Hyponatremia and Hepatorenal Syndrome
Open to view video.
Open to view video.
Module 5 Evaluation
4 Questions
4 Questions Please complete the following evaluation form to share your feedback on this activity.
Module 6: Hepatic Encephalopathy
Module 6: Hepatic Encephalopathy
Open to view video.
Open to view video.
Module 6 Evaluation
4 Questions
4 Questions Please complete the following evaluation form to share your feedback on this activity.
Module 7: Bacterial Infections in Cirrhosis with a Focus on Spontaneous Bacterial Peritonitis
Module 7- Bacterial Infections in Cirrhosis with a Focus on Spontaneous Bacterial Peritonitis
Open to view video.
Open to view video.
Module 7 Evaluation
4 Questions
4 Questions Please complete the following evaluation form to share your feedback on this activity.
Module 8: Pulmonary Complications in Patients with Cirrhosis
Module 8: Pulmonary Complications in Patients with Cirrhosis
Open to view video.
Open to view video.
Module 8 Evaluation
4 Questions
4 Questions Please complete the following evaluation form to share your feedback on this activity.
Module 9: Does My Patient with Cirrhosis Need to be Referred for Liver Transplant?
Module 9: Does My Patient with Cirrhosis Need to be Referred for Liver Transplant?
Open to view video.
Open to view video.
Module 9 Evaluation
4 Questions
4 Questions Please complete the following evaluation form to share your feedback on this activity.
Final Evaluation
Final Evaluation
4 Questions
4 Questions Please complete the following evaluation form to share your feedback on this activity.

Learning Objective:
• Identify patients with liver disease
• Apply diagnostic tests appropriately
• Discuss important counseling
• Recognize treatment/referral priorities
• Identify first line therapies for different liver diseases
• Refer to specialist in a timely and appropriate fashion

This curriculum was developed for Primary Care Providers and any other healthcare provider interested in liver disease.

CME

Accreditation Statement

The American Association for the Study of Liver Diseases (AASLD) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

AASLD designates this enduring activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse

Amedco is accredited as a provider of continuin nursing education by the American Nurses Credentialing Center's Commission on Accreditation. This course is co-provided by Amedco and AASLD. Maximum of 4.5 contact hours.

MOC

Maintenance of Certification (MOC) Statement 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.5 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 

How to Earn/Claim MOC

 

•    For each module that you wish to claim MOC points for you must:

 

            o    Complete the pre-test

 

            o    Review/watch the slides in the presentation

 

            o    Complete the post-test and pass with a score of 70% or higher (Participants have unlimited attempts to earn the passing score.)

 

            o    Claim CME credits (ABIM Rule: MOC points must be equivalent to the amount of CME credits claimed for the activity.)

 

•    AASLD submits MOC points on behalf of its learners to ABIM once a month between 15th-20th. Points are not submitted automatically and will not display immediately on your ABIM MOC Profile.

 

•    MOC points are available for ABIM board certified physicians only.

DISCLOSURE OF CONFLICTS OF INTEREST

AASLD requires all individuals who are in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial entity producing health-care related products and/or services. Disclosures are collected prior to the start of the educational activity any potential conflicts of interest that exist are resolved prior to implementation of the activity. All disclosures are made available and communicated to the leaner prior the activity beginning.
The faculty, organizers and reviewers have reported the following disclosures:

Juan Abraldes, MD
Faculty
Nothing to disclose

Jasmahon Bajaj, MD
Faculty
Advisory Committees or Review Panels: ALF, ACG
Consulting: Salix, Norgine and Alfa-Wasserman 
Grant/Research Support: Grifols, Salix

Thomas Boyer, MD
Faculty
Consulting: Ikaria
Grant/Research Support: Ikaria

Michael Fallon, MD
Faculty
Nothing to disclose

Patrick Kamath, MD
Faculty
Advisory Committees or Review Panels: Sequana

Paul Martin, MD
Faculty
Grant/Research Support: AbbVie and Genfit

Puneeta Tandon, MD
Faculty
Nothing to disclose

Florence Wong, MD
Faculty
Speakers' Bureau: L.W. Gore & Associates

Sanjeev Arora, MD
Organizer
Advisory Committee: CDC Advisory Committee - Hep C
Grant/Research Support: Gilead, Beckman Coulter, Merck, AbbVie

Lauren Beste, MD
Organizer
Nothing to disclose

Michael Fried, MD, FAASLD
Organizer
Grant/Research Support: AbbVie, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck and NIH
Scientific Consultant: AbbVie, Bristol-Myers Squibb, Gilead Sciences, Janssen, Merck and TARGET PharmaSolutions

Guadalupe Garcia-Tsao, MD
Organizer, Faculty
Advisory Committee: Abbvie, Fibrogen

Leslie Hayes, MD
Organizer
Nothing to disclose

Patrick Horne, MSN, ARNP, FNP-BC
Organizer
Consulting: Gilead Sciences, Bristol-Myers-Squibb, AbbVie

Rennie Mills, PA-C
Organizer
Advisory Board: Gilead

Minhhuyen Nguyen, MD
Organizer
Nothing to disclose

Norah Terrault, MD
Organizer
Consulting: Dynavax Technologies, Novartis Pharmaceuticals, Echosens North America Inc
Continuing Medical Education: Practice Point Communications, Focus Medical Communications, Med IQ, PRIME Education Inc 
Educational Material Development: CCO Hepatitis

John Ward, MD
Organizer
Nothing to disclose

Stephanie Graham, MA
AASLD Staff
Nothing to disclose

Claudia Ventura
AASLD Staff
Nothing to disclose

Online Learning Committee

Calvin Q. Pan, MD, MACP, FAASLD
Reviewer
Advisory Board: BMS, Gilead, Abbvie Grants/Research Support:  Gilead, Merck  Speakers Bureau: BMS, Gilead, Abbvie, salix, Synergy

Lopa Mishra, MD, FAASLD
Reviewer
Nothing to Disclose

Gene Y Im, MD
Reviewer
Nothing to Disclose

Iris W Liou, MD
Reviewer
Nothing to Disclose

Jesse M Civan, MD
Reviewer
Education: Merck

HoChong Gilles, FNP
Reviewer
Nothing to Disclose

Julius Wilder, MD, PhD
Reviewer
Nothing to Disclose

Nicolas M Intagliata, MD
Reviewer
Consulting: Vital Therapies Grants/Research Support: Vital Therapies, Eisai, Sequana Medical

Andrew S. deLemos, MD
Reviewer
Consulting: Novartis

Samar H. Ibrahim, MBCHB
Reviewer
Nothing to Disclose

This enduring material may contain discussion of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference of an unlabeled or investigational use.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of AASLD. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

Acknowledgement of Commercial Support:
No commercial support was received for this enduring material activity.